Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Mican

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Journal of Allergy and Clinical Immunology|October 1, 1990
Arthritis and mast cell activationJ M Mican, D D Metcalfe
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1994
A retrospective analysis of bone scan abnormalities in mastocytosis: correlation with disease category and prognosisC C Chen, M P Andrich, J M Mican, et al.
American Journal of Clinical Oncology|August 1, 1994
Radiotherapy of refractory bone pain due to systemic mast cell diseaseP A Johnstone, J M Mican, D D Metcalfe, et al.
AIDS (London, England)|February 24, 2001
Alopecia universalis and Graves' disease in the setting of immune restoration after highly active antiretroviral therapyI Sereti, N J Sarlis, E Arioglu, et al.
Radiology|February 1, 1997
Systemic mastocytosis: CT and US features of abdominal manifestationsN A Avila, A Ling, A S Worobec, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1992
Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cellsA S Kirshenbaum, J P Goff, S W Kessler, et al.
Hepatology (Baltimore, Md.)|October 1, 1995
Hepatic involvement in mastocytosis: clinicopathologic correlations in 41 casesJ M Mican, A M Di Bisceglie, T L Fong, et al.
AIDS Research and Human Retroviruses|December 16, 2000
Longitudinal changes in CD4+ T cell antigen receptor diversity and naive/memory cell phenotype during 9 to 26 months of antiretroviral therapy of HIV-infected patientsJ C Gea-Banacloche, L Martino, J M Mican, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 2001
Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategiesT W Chun, J S Justement, S Moir, et al.
The Journal of Infectious Diseases|March 14, 1998
Progression of human immunodeficiency virus disease is associated with increasing disruptions within the CD4+ T cell receptor repertoireJ C Gea-Banacloche, E E Weiskopf, C Hallahan, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Journal of Allergy and Clinical Immunology|October 1, 1990
Arthritis and mast cell activationJ M Mican, D D Metcalfe
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1994
A retrospective analysis of bone scan abnormalities in mastocytosis: correlation with disease category and prognosisC C Chen, M P Andrich, J M Mican, et al.
American Journal of Clinical Oncology|August 1, 1994
Radiotherapy of refractory bone pain due to systemic mast cell diseaseP A Johnstone, J M Mican, D D Metcalfe, et al.
AIDS (London, England)|February 24, 2001
Alopecia universalis and Graves' disease in the setting of immune restoration after highly active antiretroviral therapyI Sereti, N J Sarlis, E Arioglu, et al.
Radiology|February 1, 1997
Systemic mastocytosis: CT and US features of abdominal manifestationsN A Avila, A Ling, A S Worobec, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1992
Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cellsA S Kirshenbaum, J P Goff, S W Kessler, et al.
Hepatology (Baltimore, Md.)|October 1, 1995
Hepatic involvement in mastocytosis: clinicopathologic correlations in 41 casesJ M Mican, A M Di Bisceglie, T L Fong, et al.
AIDS Research and Human Retroviruses|December 16, 2000
Longitudinal changes in CD4+ T cell antigen receptor diversity and naive/memory cell phenotype during 9 to 26 months of antiretroviral therapy of HIV-infected patientsJ C Gea-Banacloche, L Martino, J M Mican, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 2001
Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategiesT W Chun, J S Justement, S Moir, et al.
The Journal of Infectious Diseases|March 14, 1998
Progression of human immunodeficiency virus disease is associated with increasing disruptions within the CD4+ T cell receptor repertoireJ C Gea-Banacloche, E E Weiskopf, C Hallahan, et al.
Pageof 2